Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., . . . Kantarjian, H. M. (2013). Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: Results of a median 2-year follow-up of COMFORT-I. Ferrata Storti Foundation.
Chicago ZitierstilVerstovsek, Srdan, et al. Efficacy, Safety and Survival With Ruxolitinib in Patients With Myelofibrosis: Results of a Median 2-year Follow-up of COMFORT-I. Ferrata Storti Foundation, 2013.
MLA ZitierstilVerstovsek, Srdan, et al. Efficacy, Safety and Survival With Ruxolitinib in Patients With Myelofibrosis: Results of a Median 2-year Follow-up of COMFORT-I. Ferrata Storti Foundation, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.